nDatalyze Corp. is a technology company focused on developing machine-learning-based solutions for health-related applications. Its primary product, Sigmund, is an online mental health application that leverages a proprietary Reference Database to predict mental health conditions and support decision-making in the mental health sector. The company also operates the YMI division, which develops a data-driven consumer mobile health application aimed at predicting health conditions to optimize healthcare services. Additionally, nDatalyze Corp. pursues projects like Epitome, which applies Sigmund's intellectual property combined with genetic data to create a predictive platform for hockey performance targeted at sports teams. Previously involved in manufacturing small-scale bio-extractors through its MedXtractor division for botanical extractions, the company has ceased those operations to concentrate on analytics-driven health technologies. Operating in the healthcare technology space, nDatalyze Corp. emphasizes data analytics and AI to deliver specialized tools for mental health and performance prediction. Founded in 2018 and headquartered in Calgary, Alberta, Canada, it positions itself at the intersection of health tech and sports analytics.